封面
市場調查報告書
商品編碼
2018504

深部腦刺激設備市場:2026-2032年全球市場預測(依產品類型、組件、波形、電池類型、應用、最終用戶和通路分類)

Deep Brain Stimulation Devices Market by Product Type, Component, Waveform, Battery Type, Application, End User, Distribution Channel - Global Forecast 2026-2032

出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年,深部腦部刺激 (DVT) 市值將達到 17 億美元,到 2026 年將成長到 18.7 億美元,到 2032 年將達到 34.6 億美元,年複合成長率為 10.64%。

主要市場統計數據
基準年 2025 17億美元
預計年份:2026年 18.7億美元
預測年份 2032 34.6億美元
複合年成長率 (%) 10.64%

本研究旨在闡明深部腦部刺激設備的現狀,並檢驗正在改變該領域的技術、臨床和商業性趨勢。

深部腦部刺激(DBS)裝置代表了神經病學和生物醫學工程的突破性融合,為多種嚴重的神經系統疾病提供了治療性介入。隨著研究的深入,這些裝置的應用範圍已從最初用於治療運動障礙擴展到精神疾病、慢性疼痛和癲癇等新的適應症。除了其臨床意義之外,DBS技術的演進還得益於硬體的小型化、電極陣列的改進以及能夠動態響應神經訊號的封閉回路型系統的整合。

探索推動下一代腦部刺激療法發展的基本技術進步和臨床趨勢。

在技​​術創新和日益成長的臨床需求的驅動下,深部腦部刺激(DSP)設備領域發生了翻天覆地的變化。隨著定向電極和自適應刺激波形的普及,該行業正從千篇一律的治療方案轉向更精準、個人化的治療。這些改進不僅提高了治療效果,還降低了能耗,延長了電池壽命,並最大限度地減少了手術更換的需要。

美國近期採取的關稅措施對神經刺激設備的供應鏈和籌資策略產生了哪些影響?

2025年,美國對關鍵零件和成品深部腦部刺激器加徵新關稅,進一步加劇了全球供應鏈和籌資策略的複雜性。依賴進口的延長件、植入式脈衝產生器和專用導線製造商正面臨原物料成本飆升的困境,被迫重新評估其採購和生產地點。因此,關於區域製造投資和近岸外包計畫的討論日益增多,旨在降低關稅風險。

詳細介紹多方面的細分框架,重點介紹跨產品類型、組件和臨床應用的策略機會。

對深部腦部刺激 (DPS) 市場的詳細分析揭示了其在多個維度上的細分,這些細分共同構成了戰略重點領域。就產品類型而言,DPS 設備分為雙通道深層腦部刺激器和單通道 DPS 設備。雙通道 DPS 設備用於治療需要雙側刺激的複雜運動障礙,而單通道深層腦部刺激器則針對單側治療即可滿足需求的特定疾病進行了最佳化。組件細分包括延長線、植入式脈衝產生器、導線和程式設計器。就導線而言,定向導線可集中輸送電流,而全定向線則提供更廣泛的刺激區域。編程器分為兩類:一類是供醫療專業人員進行詳細參數設定的編程器,另一類是供患者在家中進行即時調整的編程器。

闡明影響神經刺激療法在全球傳播的獨特區域促進因素和市場動態。

在美洲、歐洲、中東、非洲和亞太地區,區域趨勢正以不同的方式影響深部腦部刺激(DSP)技術的發展和普及。在美洲,完善的臨床基礎設施和有利的報銷環境持續推動著該設備的普及。大型神經外科中心在手術數量方面處於領先地位,而合作研究網路則正在加速新適應症(例如難治性精神障礙)的臨床試驗。

對腦刺激療法領域現有領導企業與推動創新的新興參與企業之間的競爭格局進行分析。

深部腦部刺激(DPS)領域的競爭格局呈現出成熟醫療設備領導企業,鞏固了其主導地位。這些成熟公司受益於強大的全球分銷網路、豐富的臨床數據支持其安全性和有效性,以及對下一代硬體創新的持續投入。

概述創新夥伴關係和業務運作中面臨的策略挑戰,以加速神經刺激療法的發展。

尋求在深部腦部刺激 (DSP) 領域實現永續成長的產業領導者必須優先考慮在三個方面進行策略調整:創新、夥伴關係和市場准入。首先,將研發投資集中於自適應和封閉回路型刺激平台,將滿足精準治療的需求,並在競爭激烈的市場中脫穎而出。同時,與大學附屬醫院和神經科學研究聯盟建立合作關係,將加速為運動障礙以外的新適應症提供臨床證據。

關於我們嚴謹設計的多面向調查方法,這是我們進行深部腦部刺激市場分析的基礎。

本分析基於多層次研究框架,結合了訪談、文獻回顧和資料三角驗證。訪談包括對神經外科醫師、醫療保健管理人員、供應鏈高階主管和醫療設備製造商進行結構化訪談,以直接了解臨床療效、採購趨勢和新興發展。二級資訊來源包括同行評審期刊、會議論文集、監管文件和公司資訊披露,以檢驗市場動態和技術發展。

持續創新和策略調整如何塑造神經刺激療法的未來:概要

深部腦部刺激裝置已成為一種變革性治療方法,這得益於持續的技術進步和不斷擴大的臨床適應症。自適應刺激系統、微型植入式硬體和數據驅動程式設計平台的協同作用,為個人化神經調控療法奠定了基礎,其療效遠遠超越了傳統運動障礙治療的範圍。儘管近期關稅調整帶來了一些挑戰,但該行業的韌性顯而易見,這體現在其策略性的價值鏈重組和對價值醫療的堅定不移的關注上。

目錄

第1章:序言

第2章:調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣,2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章:美國關稅的累積影響,2025年

第7章:人工智慧的累積影響,2025年

第8章:深部腦部刺激設備市場:依產品類型分類

  • 雙通道深部腦部刺激器
  • 單通道深部腦部刺激器

第9章:深部腦部刺激設備市場:依組件分類

  • 延長線
  • 植入式脈衝產生器(IPG)
  • 帶領
    • 定向引線
    • 全嚮導線
  • 程式設計師
    • 臨床程式設計師
    • 患者規劃師

第10章:依波形分類的深部腦部刺激設備市場

  • 自適應刺激
  • 穩態刺激

第11章 深部腦部刺激設備市場:依電池類型分類

  • 不可充電
  • 可充電的

第12章 深部腦部刺激設備市場:依應用領域分類

  • 慢性疼痛
  • 憂鬱症
  • 肌張力不全症
  • 癲癇
  • 自發性震顫
  • 強迫症(OCD)
  • 帕金森氏症
  • 妥瑞症

第13章 深部腦部刺激設備市場:依最終用戶分類

  • 門診手術中心
  • 醫院
  • 神經科診所
  • 研究中心

第14章 深部腦部刺激設備市場:依通路分類

  • 離線
  • 線上

第15章:深部腦部刺激設備市場:依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章 深部腦部刺激設備市場:依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章 深部腦部刺激設備市場:依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章:美國深部腦部刺激設備市場

第19章:中國深部腦部刺激設備市場

第20章 競爭格局

  • 市場集中度分析,2025年
    • 濃度比(CR)
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析,2025 年
  • 2025年產品系列分析
  • 基準分析,2025 年
  • Abbott Laboratories
  • Aleva Neurotherapeutics SA
  • Beijing Pinchi Medical Equipment Co., Ltd.
  • Boston Scientific Corporation
  • BrainsWay Ltd.
  • Fisher Wallace Laboratories LLC
  • LivaNova PLC
  • Medtronic plc
  • Neuro Device Group SA
  • Neuroelectrics Barcelona SLU
  • Neuropace, Inc.
  • Neurosoft LLC
  • Nexstim Oyj
  • Renishaw plc
  • Soterix Medical Inc.
Product Code: MRR-A339DAEFA5B6

The Deep Brain Stimulation Devices Market was valued at USD 1.70 billion in 2025 and is projected to grow to USD 1.87 billion in 2026, with a CAGR of 10.64%, reaching USD 3.46 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.70 billion
Estimated Year [2026] USD 1.87 billion
Forecast Year [2032] USD 3.46 billion
CAGR (%) 10.64%

Unveiling the Current State of Deep Brain Stimulation Devices and Examining the Technological, Clinical, and Commercial Dynamics Transforming the Sector

Deep brain stimulation (DBS) devices represent a revolutionary intersection of neurology and biomedical engineering, offering therapeutic interventions for a range of debilitating neurological disorders. As research unfolds, these devices have transcended their initial role in addressing movement disorders, adapting to emerging indications such as psychiatric conditions, chronic pain, and epilepsy. Beyond clinical implications, the evolving landscape of DBS technologies has been shaped by miniaturization of hardware, refinement of electrode arrays, and integration of closed-loop systems that respond dynamically to neural signals.

As the industry matures, collaboration among device manufacturers, neurosurgeons, and regulatory bodies has intensified, fostering an environment of shared innovation. With novel implantable pulse generators and advanced lead designs gaining regulatory clearance, stakeholders are now focused on optimizing patient outcomes, reducing procedural risks, and expanding access. Simultaneously, the convergence of digital health platforms and cloud-based data analytics is enabling remote monitoring and personalized therapy adjustments, reinforcing the momentum behind DBS adoption across global markets. In this context, a clear understanding of current dynamics and future trajectories is essential for investors, clinicians, and industry leaders aiming to drive growth and improve patient quality of life.

Exploring the Foundational Technological Advancements and Clinical Trends Driving the Next Generation of Brain Stimulation Therapies

The landscape of deep brain stimulation devices has undergone transformative shifts driven by technological innovation and heightened clinical demand. As directional leads and adaptive stimulation waveforms gain traction, the industry is moving away from one-size-fits-all approaches toward more precise, patient-specific therapies. These refinements have not only enhanced therapeutic efficacy but also reduced energy consumption, extending battery life and minimizing the need for surgical replacements.

Meanwhile, the rise of single-channel systems for targeted disorders has complemented the broader adoption of dual-channel stimulators in complex movement disorders. This diversification has been amplified by component-level advancements, including smaller implantable pulse generators and streamlined extension wires, fostering easier implantation and improved patient comfort. Additionally, the integration of clinician and patient programmers has empowered both healthcare providers and individuals to fine-tune stimulation parameters, accelerating a shift toward home-based management of chronic conditions. Collectively, these transformative shifts underscore a broader trend: deep brain stimulation is evolving from a niche neurosurgical intervention to a versatile platform capable of addressing an expanding spectrum of neurological and psychiatric disorders.

Assessing How Recent United States Tariff Measures Have Reshaped Supply Chains and Procurement Strategies for Neurostimulation Devices

In 2025, the introduction of new United States tariffs on critical components and finished deep brain stimulation devices has injected a layer of complexity into global supply chains and procurement strategies. Manufacturers reliant on imported extension wires, implantable pulse generators, and specialized leads have encountered rising input costs, prompting strategic reevaluations of sourcing and production footprints. This has, in turn, intensified conversations around regional manufacturing investments and nearshoring initiatives aimed at mitigating tariff exposures.

Clinicians and healthcare delivery organizations are also adapting their purchasing practices in response to increased unit costs, potentially influencing hospital budgets and the pricing structures offered to patients. While short-term pressures have emerged, some stakeholders view this period as an opportunity to streamline operations, negotiate long-term supplier agreements, and explore alternative materials or component designs. Looking ahead, the industry's ability to navigate these cumulative impacts will hinge on cross-border collaboration, agile procurement frameworks, and a willingness to innovate around cost constraints without compromising clinical performance.

Delving into the Multifaceted Segmentation Framework That Illuminates Strategic Opportunities Across Product Types Components and Clinical Applications

A nuanced view of the deep brain stimulation market reveals segmentation across multiple dimensions that collectively inform strategic focus areas. Product type divides offerings into dual-channel deep brain stimulators, which cater to complex movement disorders requiring bilateral stimulation, and single-channel deep brain stimulators, optimized for targeted conditions where unilateral therapy proves sufficient. Component segmentation encompasses extension wires, implantable pulse generators, leads, and programmers. Within leads, directional variants allow focused current steering, while omnidirectional designs deliver broad stimulation fields. Programmers break down into clinician programmers for in-depth parameter configuration and patient programmers enabling real-time home adjustments.

Waveform segmentation distinguishes adaptive stimulation, which modulates output in response to neural feedback, from constant stimulation, delivering continuous electrical pulses at preset intervals. Battery type further segments the landscape into rechargeable systems that reduce surgical interventions through in-situ energy replenishment and non-rechargeable options favored for simpler, lower-intensity therapies. Application-based segmentation underscores the device versatility across a spectrum of indications including chronic pain, depression, dystonia, epilepsy, essential tremor, obsessive-compulsive disorder, Parkinson's disease, and Tourette syndrome. End users frame the clinical delivery context, spanning ambulatory surgical centers focused on outpatient procedures, hospitals providing comprehensive neurosurgical services, specialized neurological clinics, and research centers pioneering novel protocols. Distribution channels complete the view by contrasting traditional offline procurement through medical device distributors with emerging online platforms that streamline ordering and support services. This interwoven segmentation matrix clarifies where innovation, regulatory attention, and investment are most concentrated.

Revealing the Distinct Regional Drivers and Market Dynamics That Are Shaping Neurostimulation Adoption Across Global Geographies

Regional dynamics are shaping the evolution and adoption of deep brain stimulation therapies in distinct ways across the Americas, Europe Middle East and Africa, and Asia-Pacific. In the Americas, robust clinical infrastructure and favorable reimbursement environments continue to buoy device uptake. Leading neurosurgical centers drive procedural volumes, while collaborative research networks accelerate trials in novel indications such as refractory psychiatric disorders.

Shifting to Europe, Middle East and Africa, heterogeneous regulatory frameworks and varying healthcare funding models present both challenges and opportunities. The European Union's stringent device approval pathways ensure high safety standards, while emerging markets in the Middle East and Africa show growing interest in advanced neuromodulation as they expand neurosurgical capabilities. Across Asia-Pacific, rapid technological adoption and government-driven healthcare investments underpin significant growth potential. Countries such as Japan and South Korea leverage strong domestic manufacturing ecosystems, while India and China focus on expanding access through cost-effective solutions. These regional insights highlight how economic, regulatory, and clinical factors converge to influence strategic priorities and market entry approaches.

Analyzing the Competitive Landscape of Established Leaders and Disruptive New Entrants Driving Innovation in Brain Stimulation

The competitive environment in deep brain stimulation is characterized by a blend of established medical device leaders and agile specialized firms. Leadership positions are consolidated among companies with comprehensive portfolios of pulse generators, leads, and programming platforms, leveraging long-standing collaborations with healthcare providers and research institutions. These incumbents benefit from robust global distribution networks, extensive clinical data supporting safety and efficacy, and ongoing investments in next-generation hardware innovations.

At the same time, emerging players are carving out niches through disruptive approaches, such as miniaturized IPGs, enhanced directional lead technologies, and advanced closed-loop systems. Startups and smaller firms often excel at rapid iteration and customization, partnering with academic centers to validate novel waveform algorithms and real-time sensing capabilities. Collaboration between established and emerging companies is also on the rise, as larger organizations seek to integrate breakthrough technologies while smaller innovators gain access to scale and market reach. This dynamic ecosystem underscores a competitive imperative: the ability to balance product breadth with depth of innovation will determine long-term leadership in the deep brain stimulation market.

Outlining Strategic Imperatives for Innovation Partnerships and Operations to Accelerate Growth in Neurostimulative Therapies

Industry leaders aiming to capture sustained growth in deep brain stimulation must prioritize strategic alignment across innovation, partnerships, and market access. First, channeling R&D investments toward adaptive and closed-loop stimulation platforms will address the demand for precision therapies and differentiate offerings in a crowded landscape. Concurrently, forging alliances with academic medical centers and neuroscience research consortia will accelerate clinical evidence generation for novel indications beyond movement disorders.

On the manufacturing front, diversifying supply chains through regional production hubs can mitigate tariff-induced cost pressures while enhancing responsiveness to local market requirements. Engagement with payers and health technology assessment bodies should focus on illustrating long-term value through cost-effectiveness studies and real-world evidence. Digital initiatives centered on remote programming, patient engagement apps, and predictive maintenance of implanted systems can deepen customer loyalty and improve therapy adherence. Ultimately, a holistic approach that interlinks technology leadership, evidence-based value propositions, and agile operational models will empower companies to navigate complexity and unlock emerging opportunities in the global DBS arena.

Describing the Rigorously Designed Multi-Source Research Methodology Underpinning Our Deep Brain Stimulation Market Analysis

This analysis is grounded in a multi-tiered research framework combining primary interviews, secondary literature review, and data triangulation. Primary research involved structured interviews with neurosurgeons, healthcare administrators, supply chain executives, and device manufacturers to capture firsthand insights into clinical efficacy, procurement dynamics, and emerging trends. Secondary sources encompassed peer-reviewed journals, conference proceedings, regulatory filings, and company disclosures to validate market dynamics and technological developments.

Quantitative data was validated through cross-referencing import/export records, tariff documentation, and device registration databases. The segmentation framework was crafted by synthesizing product catalogs, clinical trial repositories, and patient registry analyses. Regional dynamics and competitive intelligence were informed by geopolitical risk assessments, reimbursement policy reviews, and patent landscape evaluations. Throughout the research process, methodological rigor was maintained by adhering to transparency standards, ensuring reproducibility of findings, and mitigating bias through diverse expert inputs.

Summarizing How Continued Innovation and Strategic Adaptation Are Shaping the Future Trajectory of Neurostimulation Therapies

Deep brain stimulation devices have emerged as a transformative therapeutic modality, underpinned by continuous technological refinements and expanding clinical indications. The interplay between adaptive stimulation systems, miniaturized implantable hardware, and data-driven programming platforms has set the stage for personalized neuromodulation therapies that extend well beyond traditional movement disorder applications. Despite challenges posed by recent tariff adjustments, the industry's resilience is evident in strategic supply chain realignments and an unwavering focus on value-based care.

Looking forward, the path to sustained growth will hinge on collaborative innovation, robust clinical evidence generation, and agile market entry strategies tailored to diverse regional landscapes. As manufacturers and healthcare stakeholders align around these priorities, deep brain stimulation is poised to deliver profound improvements in patient outcomes, redefine standards of care, and unlock new avenues for neurological and psychiatric treatment.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Deep Brain Stimulation Devices Market, by Product Type

  • 8.1. Dual-Channel Deep Brain Stimulators
  • 8.2. Single-Channel Deep Brain Stimulators

9. Deep Brain Stimulation Devices Market, by Component

  • 9.1. Extension Wires
  • 9.2. Implantable Pulse Generator (IPG)
  • 9.3. Leads
    • 9.3.1. Directional Leads
    • 9.3.2. Omnidirectional Leads
  • 9.4. Programmers
    • 9.4.1. Clinician Programmer
    • 9.4.2. Patient Programmer

10. Deep Brain Stimulation Devices Market, by Waveform

  • 10.1. Adaptive Stimulation
  • 10.2. Constant Stimulation

11. Deep Brain Stimulation Devices Market, by Battery Type

  • 11.1. Non-Rechargeable
  • 11.2. Rechargeable

12. Deep Brain Stimulation Devices Market, by Application

  • 12.1. Chronic Pain
  • 12.2. Depression
  • 12.3. Dystonia
  • 12.4. Epilepsy
  • 12.5. Essential Tremor
  • 12.6. Obsessive-Compulsive Disorder (OCD)
  • 12.7. Parkinson's Disease
  • 12.8. Tourette Syndrome

13. Deep Brain Stimulation Devices Market, by End User

  • 13.1. Ambulatory Surgical Centers
  • 13.2. Hospitals
  • 13.3. Neurological Clinics
  • 13.4. Research Centers

14. Deep Brain Stimulation Devices Market, by Distribution Channel

  • 14.1. Offline
  • 14.2. Online

15. Deep Brain Stimulation Devices Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Deep Brain Stimulation Devices Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Deep Brain Stimulation Devices Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Deep Brain Stimulation Devices Market

19. China Deep Brain Stimulation Devices Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. Abbott Laboratories
  • 20.6. Aleva Neurotherapeutics SA
  • 20.7. Beijing Pinchi Medical Equipment Co., Ltd.
  • 20.8. Boston Scientific Corporation
  • 20.9. BrainsWay Ltd.
  • 20.10. Fisher Wallace Laboratories LLC
  • 20.11. LivaNova PLC
  • 20.12. Medtronic plc
  • 20.13. Neuro Device Group S.A.
  • 20.14. Neuroelectrics Barcelona S.L.U.
  • 20.15. Neuropace, Inc.
  • 20.16. Neurosoft LLC
  • 20.17. Nexstim Oyj
  • 20.18. Renishaw plc
  • 20.19. Soterix Medical Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY WAVEFORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY BATTERY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DUAL-CHANNEL DEEP BRAIN STIMULATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DUAL-CHANNEL DEEP BRAIN STIMULATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DUAL-CHANNEL DEEP BRAIN STIMULATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY SINGLE-CHANNEL DEEP BRAIN STIMULATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY SINGLE-CHANNEL DEEP BRAIN STIMULATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY SINGLE-CHANNEL DEEP BRAIN STIMULATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY EXTENSION WIRES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY EXTENSION WIRES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY EXTENSION WIRES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE PULSE GENERATOR (IPG), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE PULSE GENERATOR (IPG), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE PULSE GENERATOR (IPG), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY LEADS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY LEADS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY LEADS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY LEADS, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DIRECTIONAL LEADS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DIRECTIONAL LEADS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DIRECTIONAL LEADS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY OMNIDIRECTIONAL LEADS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY OMNIDIRECTIONAL LEADS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY OMNIDIRECTIONAL LEADS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMERS, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CLINICIAN PROGRAMMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CLINICIAN PROGRAMMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CLINICIAN PROGRAMMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PATIENT PROGRAMMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PATIENT PROGRAMMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PATIENT PROGRAMMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY WAVEFORM, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY ADAPTIVE STIMULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY ADAPTIVE STIMULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY ADAPTIVE STIMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CONSTANT STIMULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CONSTANT STIMULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CONSTANT STIMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY BATTERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY NON-RECHARGEABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY NON-RECHARGEABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY NON-RECHARGEABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY RECHARGEABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY RECHARGEABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY RECHARGEABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CHRONIC PAIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CHRONIC PAIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DEPRESSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DEPRESSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DEPRESSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DYSTONIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DYSTONIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DYSTONIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY EPILEPSY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY EPILEPSY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY ESSENTIAL TREMOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY ESSENTIAL TREMOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY ESSENTIAL TREMOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY OBSESSIVE-COMPULSIVE DISORDER (OCD), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY OBSESSIVE-COMPULSIVE DISORDER (OCD), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY OBSESSIVE-COMPULSIVE DISORDER (OCD), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PARKINSON'S DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PARKINSON'S DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY TOURETTE SYNDROME, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY TOURETTE SYNDROME, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY TOURETTE SYNDROME, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY NEUROLOGICAL CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY NEUROLOGICAL CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY NEUROLOGICAL CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY RESEARCH CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY RESEARCH CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY RESEARCH CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY LEADS, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMERS, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY WAVEFORM, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY BATTERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY LEADS, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMERS, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY WAVEFORM, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY BATTERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY LEADS, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMERS, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY WAVEFORM, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY BATTERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY LEADS, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMERS, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY WAVEFORM, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY BATTERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY LEADS, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMERS, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY WAVEFORM, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY BATTERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY LEADS, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMERS, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY WAVEFORM, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY BATTERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY LEADS, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMERS, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY WAVEFORM, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY BATTERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY LEADS, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMERS, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY WAVEFORM, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY BATTERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY LEADS, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMERS, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY WAVEFORM, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY BATTERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 187. GCC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. GCC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. GCC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 190. GCC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY LEADS, 2018-2032 (USD MILLION)
  • TABLE 191. GCC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMERS, 2018-2032 (USD MILLION)
  • TABLE 192. GCC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY WAVEFORM, 2018-2032 (USD MILLION)
  • TABLE 193. GCC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY BATTERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. GCC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. GCC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. GCC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY LEADS, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMERS, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY WAVEFORM, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY BATTERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY LEADS, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMERS, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY WAVEFORM, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY BATTERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 217. G7 DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 218. G7 DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. G7 DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 220. G7 DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY LEADS, 2018-2032 (USD MILLION)
  • TABLE 221. G7 DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMERS, 2018-2032 (USD MILLION)
  • TABLE 222. G7 DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY WAVEFORM, 2018-2032 (USD MILLION)
  • TABLE 223. G7 DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY BATTERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. G7 DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. G7 DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 226. G7 DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 227. NATO DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 228. NATO DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. NATO DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 230. NATO DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY LEADS, 2018-2032 (USD MILLION)
  • TABLE 231. NATO DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMERS, 2018-2032 (USD MILLION)
  • TABLE 232. NATO DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY WAVEFORM, 2018-2032 (USD MILLION)
  • TABLE 233. NATO DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY BATTERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. NATO DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. NATO DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 236. NATO DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 237. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY LEADS, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMERS, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY WAVEFORM, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY BATTERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED STATES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 249. CHINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. CHINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 251. CHINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY LEADS, 2018-2032 (USD MILLION)
  • TABLE 252. CHINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMERS, 2018-2032 (USD MILLION)
  • TABLE 253. CHINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY WAVEFORM, 2018-2032 (USD MILLION)
  • TABLE 254. CHINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY BATTERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. CHINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 256. CHINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 257. CHINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)